Select Medical ( (SEM) ) has released its Q4 earnings. Here is a breakdown of the information Select Medical presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States, offering healthcare services through a vast network of facilities across multiple states.
In its latest earnings report for the fourth quarter and year ended December 31, 2024, Select Medical announced a revenue increase of 7.8% for the quarter and 7.5% for the year, alongside strategic financial maneuvers such as the tax-free distribution of Concentra shares and adjustments in its debt structure.
The company’s key financial highlights include a revenue increase to $1,312.6 million in Q4 2024, with an adjusted EBITDA rise of 3.8% to $116.0 million, despite net losses due to one-time expenses related to stock compensation and debt retirement. Full-year revenue reached $5,187.1 million, with a 14.4% increase in adjusted EBITDA to $510.4 million. Select Medical also declared a cash dividend and announced a stock repurchase program worth up to $1.0 billion.
Looking ahead, Select Medical projects its 2025 revenue to be between $5.4 billion and $5.6 billion, with adjusted EBITDA ranging from $520.0 million to $540.0 million, indicating a positive growth trajectory. The company remains focused on operational improvements and strategic initiatives to enhance shareholder value.
